Recent study raises concerns about melatonin's link to heart failure, but experts urge caution. Learn what the research really says about this popular sleep aid and its safety.
Scientists have produced the most comprehensive brain maps, detailing how stem cells evolve into various brain cell types during critical developmental stages. This groundbreaking research could transform our understanding of neurological disorders.
A groundbreaking study reveals that taking as few as 3,000 to 5,000 steps daily can significantly slow cognitive decline in older adults at risk for Alzheimer’s disease. Discover how simple movements can protect your brain!
A new study reveals that obstructive sleep apnea is not just an inconvenience – it could increase your risk of dementia and Alzheimer's through brain microbleeds. Experts urge immediate action!
As autumn sets in, many experience the winter blues. Learn about seasonal affective disorder (SAD), its effects on mood, and how light therapy can help combat these seasonal changes.
Young Russians are flocking to a cheap weight-loss pill called Molecule, lured by TikTok trends. But behind the promise of rapid weight loss lies a dangerous substance linked to severe health risks and hospitalizations.
A new study reveals alarming links between maternal Covid-19 infections during pregnancy and increased risks of autism and other neurodevelopment disorders in children. Researchers found a significant rise in diagnoses among affected children, especially boys.
A groundbreaking study reveals that dreaming occurs even in deep sleep, challenging the long-held belief that only REM sleep is responsible for our dreams. Discover how this research could change our understanding of consciousness and sleep.
Are you feeling a dip in mood and energy as autumn arrives? Discover how light therapy can help combat seasonal depression and improve your well-being this winter. Learn expert tips on using light boxes effectively.
A groundbreaking gene therapy has shown it can slow the progression of Huntington's disease by 75% in a small clinical trial. This one-time treatment could reshape the future for patients with this rare brain disorder.